SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,201.74 |
| Enterprise Value ($M) | 1,898.90 |
| Book Value ($M) | 289.06 |
| Book Value / Share | 4.56 |
| Price / Book | 7.62 |
| NCAV ($M) | 284.63 |
| NCAV / Share | 4.49 |
| Price / NCAV | 7.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.77 |
| Return on Equity (ROE) | -1.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.76 |
| Current Ratio | 13.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 364.13 |
| Assets | 368.56 |
| Liabilities | 79.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Avoro Capital Advisors LLC | 7.90 | ||
| 13G/A | Kynam Capital Management, LP | 2.49 | -56.81 | |
| 13G | Price T Rowe Associates Inc /md/ | 7.20 | ||
| 13G/A | Commodore Capital Lp | 7.30 | -28.44 | |
| 13G/A | Fmr Llc | 5.08 | 0.39 | |
| 13D/A | Longitude Capital Partners IV, LLC | 8.40 | 0.39 | |
| 13D/A | Sofinnova Venture Partners X, L.P. | 5.40 | -22.87 | |
| 13G/A | Ares Trading S.A. | 3.60 | 0.00 | |
| 13G/A | Citadel Advisors Llc | 0.10 | ||
| 13G | Woodline Partners LP | 2.20 | ||
| 13G | BlackRock, Inc. | 6.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 185,451 | 619,717 | 29.93 | |
| 309,316 | 1,339,453 | 23.09 | |
| 149,074 | 877,166 | 16.99 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TVTX – Travere Therapeutics, Inc. | URGN – UroGen Pharma Ltd. |
| VCEL – Vericel Corporation | VNDA – Vanda Pharmaceuticals Inc. |
| VRCA – Verrica Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io